LENZ Therapeutics Inc
Biotechnology
Healthcare
LENZ
28.08 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
41.50
52 week high
42.27
high
41.99
52 week low
0.00
previous Close
41.26
P/E ratio
market cap
916 M
div yield
0
net incoming
-14.91 M
-2.00 %
net profit margin
-298.24 %
-298.00 %
operating incoming
-16.86 M
0.44 %
net change in cash
14.57 M
405.06 %
cash on hand
37.61 M
63.21 %
top